Boston Partners’s Arcosa ACA Stock Holding History
Bought
Maintained
Sold
Other funds holding ACA
NAMI
RA
Boston Partners's ACA Position: Q2 2026 in Review
Boston Partners reduced its Arcosa (ACA) stake by 1.5% in Q2 2026, selling an estimated $68.7K and leaving 36,346 shares worth $2.35M. The position accounts for ﹤0.01% of the portfolio, ranked #582.
Boston Partners first reported a position in ACA in Q4 2022 and has held it in 15 quarters since. The position peaked at $29M in Q2 2024. 428 funds tracked by Wall St. Rank hold ACA as of Q2 2026.
- Boston Partners held 36,346 shares of Arcosa worth $2.35M as of Q2 2026.
- Boston Partners sold 553 Arcosa shares in Q2 2026, an estimated $68.7K.
- Arcosa made up ﹤0.01% of Boston Partners's portfolio in Q2 2026, its #582 holding.
- Boston Partners first reported a position in Arcosa in Q4 2022 and has held it in 15 quarters since.
- Boston Partners's Arcosa position peaked at $29M in Q2 2024.
- 428 funds tracked by Wall St. Rank held Arcosa as of Q2 2026.
Based on Boston Partners's 13F filing for Q2 2026, filed 4 Aug 2026.